Journals / International Journal of Plant Based Pharmaceuticals / 2022 / Cilt: 2 - Sayı: 1

Natural phenolic compounds from Satureja L. as inhibitors of COVID-19 protease (Mpro): Computational investigations

Pages
111–117
Publication Date
2022-06-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The study proved that three different phenolic compounds namely 5,6-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-7,8-dimethoxy-4H-chromen-4-one, 2-(3,4-dimethoxyphenyl)-5,6-dihydroxy-7,8-dimethoxy-4H-chromen-4-one, and 5,6-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7,8-dimethoxy-4H-chromen-4-one obtained from Satureja L. taxa were found as promising against SARS-CoV-2 main protease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Coronavirus (SARS-CoV-2) causes a new type of severe acute respiratory syndrome that first appeared in Wuhan in December 2019; it is a very fast-spreading and deadly virus.
📊
Key Findings & Data:This study aimed to investigate the SARS-CoV-2 protease inhibition potential of the phenolic compounds in the genus Satureja L.
💡
Conclusion & Impact:The study proved that three different phenolic compounds namely 5,6-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-7,8-dimethoxy-4H-chromen-4-one, 2-(3,4-dimethoxyphenyl)-5,6-dihydroxy-7,8-dimethoxy-4H-chromen-4-one, and 5,6-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7,8-dimethoxy-4H-chromen-4-one obtained from Satureja L. taxa were found as promising against SARS-CoV-2 main protease.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Satureja L. · Phenolic compounds · COVID-19

Abstract

Coronavirus (SARS-CoV-2) causes a new type of severe acute respiratory syndrome that first appeared in Wuhan in December 2019; it is a very fast-spreading and deadly virus. Therefore, urgent discovery or development of “lead compounds” against this virus is crucial. Natural compounds have always served as a great source, especially the use of traditional medicinal plants, in modern drug discovery. This study aimed to investigate the SARS-CoV-2 protease inhibition potential of the phenolic compounds in the genus Satureja L. The affinities of the chosen natural products were understood using molecular docking simulation against the SARS-CoV-2 protease enzyme. The study proved that three different phenolic compounds namely 5,6-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-7,8-dimethoxy-4H-chromen-4-one, 2-(3,4-dimethoxyphenyl)-5,6-dihydroxy-7,8-dimethoxy-4H-chromen-4-one, and 5,6-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7,8-dimethoxy-4H-chromen-4-one obtained from Satureja L. taxa were found as promising against SARS-CoV-2 main protease.

🔖

Cite This Article

BAŞOĞLU, F., TUFAN, S., TAN, N. (2022). Natural phenolic compounds from Satureja L. as inhibitors of COVID-19 protease (Mpro): Computational investigations. International Journal of Plant Based Pharmaceuticals, Cilt: 2 - Sayı: 1, 111–117. https://ajindex.com/articles/852764

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Abad, M.J., Bermejo, P., Gonzales, E., Iglesias, I., Irurzun, A., Carrasco, L., 1999. Antiviral activity of Bolivian plant extracts. General Pharmacology: The Vascular System, 32(4), 499-503.
  2. Abdollahi, M., Salehnia, A., Mortazavi, S.H.R., Ebrahimi, M., Shafiee, A., Fouladian, F., Kazemi, A., 2003. Antioxidant, antidiabetic, anti-hyperlipidemic, reproduction stimulatory properties and safety of essential oil of Satureja khuzestanica in rat in vivo: a toxicopharmacological study. Medical Science Monitor, 9(9), BR331-BR335. Amanlou, M., Dadkhah, F., Salehnia, A., Farsam, H., Dehpour, A.R., 2005. An anti-inflammatory and anti-nociceptive effects of hydroalcoholic extract of Satureja khuzistanica Jamzad extract. Journal of Pharmaceutical Sciences, 8(1), 102-106.
  3. Askun, T., Tekwu, E.M., Satil, F., Modanlioglu, S., Aydeniz, H., 2013. Preliminary antimycobacterial study on selected Turkish plants (Lamiaceae) against Mycobacterium tuberculosis and search for some phenolic constituents. BMC Complementary and Alternative Medicine, 13(1), 1-11.
  4. Barnes, J., Anderson, L.A., Phillipson, J.D., 2007. Herbal Medicines: a guide for healthcare professionals. London: Pharmaceutical Press.
  5. Başoğlu, F., Ulusoy‐Güzeldemirci, N., Akalın‐Çiftçi, G., Çetinkaya, S., Ece, A., 2021. Novel imidazo [2, 1‐b] thiazole‐based anticancer agents as potential focal adhesion kinase inhibitors: synthesis, in silico, and in vitro evaluation. Chemical Biology & Drug Design, 98(2), 270-282
  6. Bekut, M., Brkić, S., Kladar, N., Dragović, G., Gavarić, N., Božin, B., 2018. Potential of selected Lamiaceae plants in anti (retro) viral therapy. Pharmacological Research, 133, 301-314.
  7. Cetojevic-Simin, D.D., Bogdanovic, G.M., Cvetkovic, D.D., Velicanski, A.S., 2008. Antiproliferative and antimicrobial activity of traditional Kombucha and Satureja montana L. Kombucha. Journal of BUON, 13(3), 395-401.
  8. Cetojevic-Simin, D.D., Canadanovic-Brunet, J.M., Bogdanovic, G.M., Cetkovic, G.S., Tumbas, V.T., Djilas, S.M., 2004. Antioxidative and antiproliferative effects of Satureja montana L. extracts. Journal of BUON, 9(4), 443-449.
  9. Cetojevic-Simin, D.D., Velićanski, A.S., Cvetković, D.D., Markov, S.L., Mrđanović, J.Ž., Bogdanović, V.V., Šolajić, S.V., 2012. Bioactivity of lemon balm kombucha. Food and Bioprocess Technology, 5(5), 1756-1765.
  10. Chorianopoulos, N., Evergetis, E., Mallouchos, A., Kalpoutzakis, E., Nychas, G.J., Haroutounian, S.A., 2006. Characterization of the essential oil volatiles of Satureja thymbra and Sa